ctDNA analysis of patients (pts) with unresectable hepatocellular carcinoma (uHCC) treated with lenvatinib (LEN) or sorafenib (SOR) as 1L therapy.

Journal

Journal of Clinical Oncology

Series/Report No.

Journal of Clinical Oncology

Journal Volume

42

Start Page

4094

End Page

4094

Date Issued

2024-06-01

Author(s)

Evans T.R.J.

Kudo, Masatosh

Wyrwicz, Lucjan S.

Ngan, Roger KC

Blanc, Jean-Frédéric

Baron, Ari David

Vogel, Arndt

et al.

URI

Type

review article